Vaccinations with Johnson & Johnson’s coronavirus vaccine may resume immediately, Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said Friday.
The CDC and the US Food and Drug Administration lifted their recommendation for pausing use of the company’s Janssen vaccine after CDC advisers recommended it.
“We are no longer recommending a pause to the Johnson and Johnson vaccine,” Walensky said at a news conference. “I support the ACIP’s recommendation that the Johnson and Johnson Covid-19 vaccine be used for persons 18 years of age or older in the United States population under the FDA emergency use authorization, and I have signed this recommendation."
“With these actions, the administration of Johnson and Johnson's Covid-19 vaccine can resume immediately," Walensky added.
Certain women under the age of 50 may have a small risk of developing a rare blood clotting syndrome, Walensky said.
“There is likely an association but the risk is very low,” Walensky said.